Approved by
Russian Federation
Government Regulation N 830
dated November 30th, 2001
CUSTOMS TARIFF OF THE RUSSIAN FEDERATION
Section VI
PRODUCTS OF CHEMICAL INDUSTRY AND OF RELATED BRANCHES
Group 30
Pharmaceutical products
Notices:
1. This group is exclusive of the following:
a) food products and drinks (for example, dietetic, diabetic or foodstuffs, enriched with nutritive supplements, food
supplements, tonic beverages and mineral waters), except nutrient preparations for intravenous induction (section IV);
b) special calcined or fine-powdered gypsums used for stomatological applications (commodity item 2520);
c) water distillates, water solutions of volatile oils used for medical purposes (commodity item 3301);
d) preparations under commodity items 3303 - 3307, including those of therapeutic or prophylactic character;
e) soap and other products of commodity item 3401, containing curative admixtures;
f) gypsum-based products for applications in stomatology (commodity item 3407); or
g) blood albumin, unprepared for medicative or preventive purposes (commodity item 3502).
2. In wording of commodity item 3002 the term "modified immunological products" is related solely to monoclonal
antibodies (MABs), fragments of antibodies, conjugates of antibodies and conjugates of fragments of antibodies.
3. In commodity items 3003 and 3004 and in notice 4 this group should be understood to incorporate:
a) unmixed products, understood as:
1) unmixed water-dissolved products;
2) all goods, included into group 28 or 29; and
3) simple plant-extracted products, included into commodity item 1302, but standardized or dissolved in any
soluable;
b) mixed products understood as:
1) colloidal solutions and suspensions (except colloidal sulphur);
2) plant-extracted products, derived by treatment of mixtures of plant materials; and
3) salts and concentrates, derived by graduation of natural mineral waters.
4. Commodity item 3006 includes only the following products, which must be incorporated solely into this particular
commodity item and into none of others of this Nomenclature:
a) sterile surgical gut, similar to sterile stitching materials and sterile adhesive tissues for surgical closing of wounds;
b) sterile kelp and sterile kelp sponges;
c) sterile absorbent surgical or stomatological styptics (haemostatics);
d) contrast preparations for radiographic examinations and diagnostic reagents intended for patients’ administration,
namely unblended substences in dosated forms or substences, compounded of two or more components, blended for this
purpose;
e) reagents for blood grouping;
f) dental cements and other dental filler materials; and other materials for tooth stopping; cements for bone
reconstruction;
g) medicine bags and first-aid kits; and
h) hormone-based contraceptives, other compounds under commodity item 2937 or spermicides;
i) jelly preparations for medicative or veterinary applications as lubricants of parts of the body during surgical
operations or physical researches, or materials binding a patient’s body with appliances; and
j) unusable phamaceuticals, namely products, which are not usable for initial purposes, for instance, as timeexpired.
┌─────────────┬─────────────────────────────────────────┬────┬───────────────────┐
│
Code of
│
│Extra│ Import customs
│
│
Foreign
│
│unit│
rate of duty
│
│
Economic │
Commodity item
│ of │ (in percentage of │
│
Activity │
│mea-│ customs value or │
│ Commodity │
│sure│
in Euro)
│
│ Nomenclature│
│ment│
│
├─────────────┼─────────────────────────────────────────┼────┼───────────────────┤
│3001
│ Glands and other organs, intended
│
│
│
│
│ for histotherapy, dried,
│
│
│
│
│ pulverized or not pulverized;
│
│
│
│
│ glands humors, humors from other organs │
│
│
│
│ and their secretions, intended
│
│
│
│
│ for histotherapy; heparin and its salts;│
│
│
│
│ other materials of human or
│
│
│
│
│ animal nature, intended
│
│
│
│
│ for therapeutic or prophylactic
│
│
│
│
│ purposes, not included or named:
│
│
│
│3001 10
│ - glands and other organs, dried,
│
│
│
│
│ pulverized or not pulverized
│
│
│
│3001 10 100 0│ - - pulverized
│ - │
10
│
│3001 10 900 0│ - - other
│ - │
10
│
│3001 20
│ - gland humors or humors from other
│
│
│
│
│ organs and their secretions:
│
│
│
│3001 20 100 0│ - - of human nature
│ - │
10
│
│3001 20 900 0│ - - other
│ - │
10
│
│3001 90
│ - other:
│
│
│
│3001 90 100 0│ - - of human nature
│ - │
10
│
│
│ - - other:
│
│
│
│3001 90 910 0│ - - - heparin and its salts
│ - │
10
│
│3001 90 990 0│ - - - other
│ - │
10
│
│3002
│ Human blood; animal blood,
│
│
│
│
│ prepared for
│
│
│
│
│ therapeutic, prophylactic or
│
│
│
│
│ diagnostic purposes; immune
│
│
│
│
│ serum and other blood fractions and
│
│
│
│
│ modified immunological
│
│
│
│
│ products, including products received by│
│
│
│
│ the methods of bioengineering; vaccines,│
│
│
│
│ toxins, germ cultures
│
│
│
│
│ (except yeast) and similar products:
│
│
│
│3002 10
│ - immune serum and other blood
│
│
│
│
│ fractions and modified
│
│
│
│
│ immunological products, including
│
│
│
│
│ products received by the methods
│
│
│
│
│ of bioengineering:
│
│
│
│3002 10 100 │ - - immune serum:
│
│
│
│3002 10 100 1│ - - - against snake venom
│ - │
5
│
│3002 10 100 9│ - - - other
│ - │
15
│
│
│ - - other:
│
│
│
│3002 10 910 0│ - - - hemoglobulin, blod globulin blood │ - │
10
│
│
│
and seroglobulins
│
│
│
│
│ - - - other:
│
│
│
│3002 10 950 │ - - - - of human nature:
│
│
│
│3002 10 950 1│ - - - - - blood coagulation factors
│ - │
5
│
│3002 10 950 9│ - - - - - other
│ - │
10
│
│3002 10 990 0│ - - - - other
│ - │
10
│
│3002 20 000 │ - vaccines for people:
│
│
│
│3002 20 000 1│ - - against rubella
│ - │
5
│
│3002 20 000 2│ - - B hepatitis B vaccine
│ - │
5
│
│3002 20 000 9│ - - other
│ - │
10
│
│3002 30 000 0│ - veterinary vaccines
│ - │
10
│
│3002 90
│ - other:
│
│
│
│3002 90 100 0│ - - human blood
│ - │
10
│
│3002 90 300 0│ - - animal blood, prepared for
│ - │
10
│
│
│
therapeutic, prophylactic
│
│
│
│
│
or diagnostic purposes
│
│
│
│3002 90 500 0│ - - germ cultures
│ - │
10
│
│3002 90 900 0│ - - other
│ - │
10
│
│3003
│ Medicinal agents (except commodity
│
│
│
│
│
│
│
│
│
│3003
│
│
│
│
│3003
│
│
│
│
│
│3003
│3003
│3003
│
│
│
│3003
│
│
│
│3003
│3003
│3003
│
│
│
│3003
│3003
│
│3003
│3003
│
│
│
│3003
│3004
│
│
│
│
│
│
│
│
│3004
│
│
│
│
│3004
│
│
│
│3004
│
│
│
10 000
10 000
10 000
20 000
20 000
20 000
31 000
39 000
40 000
90
90 100
90 900
90 900
90 900
10
10 100
10 100
│
│
│
│
│
│
│
│
│
│
│
1│
│
│
│
│
│
9│
│
1│
│
│
│
9│
│
│
│
0│
0│
0│
│
│
│
│
0│
│
│
1│
│
│
│
9│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
1│
│
│
│
items 3002, 3005 or 3006), consisting
│
of mixtures of two or more components, │
for therapeutic or prophylactic
│
purposes, but not packaged in the form │
of measured dosage bands or in retail
│
packs:
│
- containing penicillins or their
│
derivative substances, with
│
penicillanic acid structure, or
│
containing streptomycins or their
│
derivative substances:
│
- - containing as main functional
│
material only: ampicillin sodium
│
salt or ampicillin trihydrate, or
│
benzylpenicilloic salts and their
│
compounds, or phenoxymethylpenicillin,│
or oxacillin
│
- - other
│
- containing other antibiotics:
│
- - containing as main
│
functional materials only:
│
erythromycin base or kanamycin
│
sulphate, or streptomycin sulphate
│
- - other
│
- containing hormones or other
│
compounds of commodity item 2937, but │
not containing antibiotics:
│
- - containing insulin
│
- - other
│
- containing alkaloids or their
│
derivative substances, but not
│
containing hormones or other compounds │
of commodity item 2937 or antibiotics │
- other:
│
- - containing iodine or iodine
│
compounds
│
- - other:
│
- - - containing as main functional
│
materials only:
│
calcium gluconate or acetylsalicylic│
acid, or paracetamol
│
- - - other
│
Medicinal agents (except products of
│
commodity items 3002, 3005 or 3006),
│
consisting of mixed or not mixed
│
products, for therapeutic or
│
prophylactic purposes,
│
packaged in the form of measured
│
dosage bands (including
│
medicinal agents in the form of
│
transdermal system) or in retail packs │
- containing penicillins or their
│
derivative substances, with
│
penicillanic acid structure, or
│
containing streptomycins or their
│
derivative substances:
│
- - containing as active
│
materials only penicillins or their
│
derivative substances, with
│
penicillanic acid structure:
│
- - - containing as main
│
functional materials only:
│
ampicillin trihydrate or ampicillin │
sodium salt, or benzylpenicillin
│
-
-
-
-
-
-
-
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
10
5
10
5
tax-free
5
5
5
10
5
15
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│3004
│
│
│3004
│3004
│
│
│
│3004
│
│
│3004
│3004
│3004
│3004
│3004
│
│
│
│
│
│
│
│
│
│
│
│
│3004
│3004
│3004
│
│
│
│3004
│
│
│
│3004
│3004
│
│3004
│3004
│
│
│3004
│
│3004
│
│
│3004
│3004
│3004
│3004
│
│3004
│3004
│
│
10 100
10 100
10 900
10 900
10
10
20
20
20
900
900
100
100
20 100
20 900
20 900
20 900
31
31 100
31 900
32
32 100
32 100
32 100
32 900
39
39 100
39 900
40
│
│
│
│
│
2│
│
│
9│
│
│
│
│
1│
│
│
2│
9│
│
│
1│
│
│
│
│
│
│
│
│
│
│
│
│
9│
│
1│
│
│
│
9│
│
│
│
│
0│
│
0│
│
│
│
│
│
1│
│
│
9│
0│
│
0│
│
0│
│
│
│
salts and compounds, or
carbenicillin, or oxacillin,
or sulacillin (sultamicillin), or
phenoxymethylpenicillin
- - - other:
- - - - packaged or produced
in the form of measured dosage
bands, but not in the retail packs
- - - - other
- - other:
- - - packaged or produced in the form,
of measured dosage bands, but
not in the retail packs
- - - - containing as main
functional materials only
streptomycin sulphate
- - - - other
- - - other
- containing other antibiotics:
- - in retail packs
- - - containing as main
functional materials only:
amikacin or gentamicin, or
griseofulvin, or doxicillin, or
doxorubicine, or kanamycin, or
fusidic acid and it sodium
salts, or chloramphenicol
(chloramphenicol) and its salts, or
lincomycin, or metacycline, or
nystatin, or rifampicin, or
cefazolin, or cefalexin, or
cefalotin, or erythromycin
base
- - - other
- - other:
- - - containing as main
functional materials only
erythromycin base or
kanamycin sulphate
- - - other
- containing hormones or other
compounds commodity item 2937, but not
containing antibiotics:
- - containing insulin:
- - - packaged im forms or in retail
packs
- - - other
- - containing corticosteroid
hormones, their derivative substances
and structural analogs:
- - - packaged in forms or in retail
packs:
- - - - containing as main
functional materials only
fluocinolon
- - - - other
- - - other
- - other:
- - - packaged in forms or in retail
packs
- - - other
- containing alkaloids or their
derivative substances, but not
containing hormones, and other
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
-
-
-
-
-
-
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
5
10
15
5
10
15
10
15
10
tax-free
tax-free
15
10
10
10
10
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│3004 40 100 │
│3004 40 100 1│
│
│
│
│
│
│
│
│
│
│
│3004 40 100 9│
│3004 40 900 0│
│3004 50
│
│
│
│
│
│3004 50 100 │
│3004 50 100 1│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│(legal wording
│3004 50 100 9│
│3004 50 900 │
│3004 50 900 1│
│
│
│
│
│3004 50 900 2│
│
│
│
│
│
│
│
│
│(legal wording
│3004 50 900 9│
│(legal wording
│3004 90
│
│
│
│3004 90 110 0│
│
│
│3004 90 190 │
│3004 90 190 1│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
compounds of commodity item
│
│
2937 or antibiotics:
│
│
- - packaged in forms or retail packs
│
│
- - - containing as main
│ - │
functional materials only:
│
│
sodium theine-benzoate or
│
│
xantinol nicotinate, or papaverine, │
│
or pilocarpine, or theobromine, or │
│
theophylline
│
│
- - - other
│ - │
- - other
│ - │
- other medicinal agents,
│
│
containing vitamins or other
│
│
compounds of commodity item 2936:
│
│
- - packaged in forms or retail packs
│
│
- - - containing as main
│ - │
functional materials only:
│
│
cevitamic acid (vitamin C) or
│
│
nicotinic acid, or
│
│
co-carboxylase, or nicotinamide, or │
│
pyridoxine, or thiamin and its salts│
│
(vitamin B1), cyanocobalamin
│
│
(vitamin B12)
│
│
of RF Government Regulation N 366, dated 30.05.2002)
- - - other
│ - │
- - other:
│
│
- - - containing as main
│ - │
functional materials only alpha │
│
tocopherol acetate (vitamin E)
│
│
- - - containing as main
│ - │
functional materials only:
│
│
co-carboxylase or cevitamic
│
│
acid (vitamin C), or
│
│
cyanocobalamin (vitamin B12)
│
│
of RF Government Regulation N 366, dated 30.05.2002)
- - - other
│ - │
of RF Government Regulation N 366, dated 30.05.2002)
- other:
│
│
- - packaged in forms or retail packs
│
│
- - - containing iodine or iodine
│ - │
compounds
│
│
- - - other:
│
│
- - - - containing as main
│ - │
functional materials only: sodium │
│
salt of adenosine triphosphoric
│
│
acid or acetylsalicylic acid
│
│
(except medicinal agents
│
│
in tabloid form, covered by
│
│
enteric coating,
│
│
containing as functional
│
│
materials acetylsalicylic acid),
│
│
or benzocaine, or
│
│
biscalcitrate (colloidal bismuth
│
│
subcitrat), or verapamil, or
│
│
gamma-aminobutyric acid, or
│
│
dibazol, or diclofenac sodium, or │
│
diphenhydramine hydrochloride, or │
│
ibuprofen, or corvalol, or validol,│
│
or isosorbide dinitrate, or inosine│
│
(riboxin), captopril, or ketamine, │
│
or ketotifen, or clozapine, or
│
│
clomifene citrate, or lidocaine, or│
│
lipoic acid, or lithium carbonate, │
│
or metazid, or metamizole
│
│
15
10
10
15
10
10
10
10
10
10
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│(legal wording
│3004 90 190 9│
│
│
│3004 90 910 0│
│
│
│(legal wording
│3004 90 990 │
│3004 90 990 1│
│
│
│
│
│
│
│
│
│(legal wording
│3004 90 990 9│
│(legal wording
│3005
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│3005 10 000 0│
│
│
│3005 90
│
│3005 90 100 0│
│
│
│
│
(analgin), or hexamine or
│
│
methyluracil, or methionine, or
│
│
metronidazole, or sodium chloride, │
│
or naphazoline, or nitroxoline, or │
│
nifedipine (except medicaments
│
│
in form of bilaminar
│
│
tablet, with laser perforation of │
│
osmotic membrane,
│
│
with polymer layer and with a layer│
│
of functional active materials │
│
nifedipine in osmotic
│
│
condition), or nicetamide, or
│
│
pancreatine, or paracetamol, or
│
│
pentaerithrityl tetranitrate, or
│
│
piperazine, or pyracetam, or
│
│
pirenoxin, or pyricarbate, or
│
│
piroxicam, or polyammine, or
│
│
polyvinyl pyrrolidone, or,
│
│
primidone or probucol, or procaine │
│
(novocaine), or propranolol,
│
│
or ranitidine,
│
│
or salbutamol, or suxamethonium,
│
│
or sulfadimethoxine,
│
│
or sulfalene, or taurine, or
│
│
phenobarbital, or
│
│
phthalyl sulfatiazol, or
│
│
furosemide, or chlorquinaldol,
│
│
or cerebrolisate, or cinnarizine, │
│
or ciprofloxacin (except
│
│
medicaments in the form of
│
│
infusion solution for
│
│
intravenous induction, containing │
│
as functional materials
│
│
ciprofloxacin), or citrapar, or
│
│
cytramon-p, or etamsylate
│
│
of RF Government Regulation N 366, dated 30.05.2002)
- - - - other
│ - │
- - other:
│
│
- - - containing iodine or iodine
│ - │
compounds
│
│
of RF Government Regulation N 366, dated 30.05.2002)
- - - other:
│
│
- - - - containing as main
│ - │
functional materials only:
│
│
acetylsalicylic acid or
│
│
paracetamol, or riboxin (inosine), │
│
or polyvinyl pyrrolidone
│
│
of RF Government Regulation N 366, dated 30.05.2002)
- - - - other
│ - │
of RF Government Regulation N 366, dated 30.05.2002)
absorbent cotton, butter-muslin,
│
│
bandages and similar products
│
│
(for example, surgical dressing,
│
│
adhesive plaster, cataplasm), sodden
│
│
or covered by pharmaceutical agents
│
│
or packaged in forms or retail packs,
│
│
intended for use in medicine, surgery, │
│
stomatology or veterinary medicine:
│
│
- adhesive surgical dressing and
│ - │
other materials, with tacky surface
│
│
- other:
│
│
- - absorbent cotton and products from │ - │
absorbent cotton
│
│
- - other:
│
│
10
10
10
10
10
10
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│
│ - - - made of textile:
│
│
│
│3005 90 310 0│ - - - - butter-muslin and products
│ - │
10
│
│
│
made of butter-muslin
│
│
│
│
│ - - - - other:
│
│
│
│3005 90 510 0│ - - - - - made of nonwoven fabric
│ - │
10
│
│3005 90 550 0│ - - - - - other
│ - │
10
│
│3005 90 990 0│ - - - other
│ - │
10
│
│3006
│ pharmaceuticals, mentioned in
│
│
│
│
│ notice 4 to this group:
│
│
│
│3006 10
│ - sterile surgical gut,
│
│
│
│
│ similar sterile materials for
│
│
│
│
│ stitching and sterile adhesive
│
│
│
│
│ tissues for surgical closing of wounds;│
│
│
│
│ sterile kelp and sterile kelp sponges; │
│
│
│
│ sterile absorptive surgical or
│
│
│
│
│ stomatological styptics (haemostatics):│
│
│
│3006 10 100 0│ - - sterile surgical gut
│ - │
5
│
│3006 10 900 0│ - - other
│ - │
5
│
│3006 20 000 0│ - reagents for blood grouping
│ - │
10
│
│3006 30 000 0│ - contrast preparations for
│ - │
10
│
│
│ radiographic examinations;
│
│
│
│
│ diagnostic reagents intended for
│
│
│
│
│ patients’ administration
│
│
│
│3006 40 000 0│ - dental cement and other materials for │ - │
10
│
│
│ tooth stopping; cements
│
│
│
│
│ for bone reconstruction
│
│
│
│3006 50 000 0│ - medicine bag and emergency kits
│ - │
10
│
│3006 60
│ - contraceptives based on hormones and │
│
│
│
│ other compounds of commodity item 2937 │
│
│
│
│ or based on spermicides:
│
│
│
│
│ - - based on hormones or other
│
│
│
│
│
compounds of commodity item 2937:
│
│
│
│3006 60 110 0│ - - - packaged in forms or retail packs │ - │
10
│
│3006 60 190 0│ - - - other
│ - │
10
│
│3006 60 900 0│ - - based on spermicides
│ - │
10
│
│3006 70 000 0│ - jelly preparations for medicative or │ - │
5
│
│
│ veterinary applications as lubricants │
│
│
│
│ of parts of the body during
│
│
│
│
│ surgical operations or physical
│
│
│
│
│ researches, or materials binding
│
│
│
│
│ a patient’s body with appliances;
│
│
│
│3006 80 000 0│ - pharmaceutical wastes
│ - │
15
│
└─────────────┴─────────────────────────────────────────┴────┴───────────────────┘